Actual enrollment decreased by 98 participants
Before: 164 participants (actual). After: 66 participants (actual).
Study sponsor: Zevra Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 164 participants (actual). After: 66 participants (actual).